Platform
How a search becomes a screened applicant.
Six things have to go right between a person typing a question into Google and a coordinator picking up the phone. Most recruitment tools own one of them. This page walks all six, in order.
A page for every study, city, condition and drug.
27,306 studies are recruiting in the United States right now, and each one has a page here.
We build those pages from the registry record itself — the NCT number, the eligibility criteria, the site list, the sponsor — and rebuild them daily from ClinicalTrials.gov via AACT. That matters more than it sounds: the reason most site websites stop earning traffic is that their study list describes protocols that closed two years ago. A page generated from the live record cannot go stale.
Patients arrive by searching the way patients actually search — a condition, a city, a drug name, sometimes the name of a specific site. So the index is organised the same way, and every page cites the NCT it came from.
The application asks the study's own questions.
A generic “I’m interested” form moves the entire eligibility problem onto your coordinator. Ours doesn’t. The wizard reads the protocol’s inclusion and exclusion criteria from the registry record and asks about the ones a patient can actually answer — age, diagnosis, current medications, prior treatment, how far they are willing to travel.
Identity is verified before submission, and applications from outside the United States are held for review rather than forwarded. What reaches you is a person who answered the real questions, with a verdict attached.
Applicants land in a workspace, not an inbox.
Every applicant becomes a record with a status — new, contacted, screening, scheduled, not a fit — plus their answers, the trial, and the location they applied to. Your teammates share it. Nothing depends on one person watching one mailbox.
If you run several locations, one sign-in switches between them. Access is by magic link, so there is no password for a coordinator to lose.
A page about the place, not just the protocol.
Patients are agreeing to months of visits to a building they have never seen. Almost nothing in this category shows them that building.
Every research site in our directory has a permanent profile with its address on a map, its Google rating where we have one, and every study it is currently running. Patients can subscribe to be told when a new trial opens there.
Find your site page →A whole site, generated from your real studies.
Home, current studies, per-study detail pages, about, contact — built from your registry record and re-synced from it. Closed studies move to an archived state rather than 404ing, which is how most research-site websites quietly lose whatever search ranking they had.
It runs on a hipa.ai subdomain immediately, and on your own domain when you want it to. There is no charge, and no exclusivity.
A no for one study is a maybe for another.
Most applicants do not fit the first study they find. Rather than losing them, the matching engine looks for another study they could join — geography, condition and eligibility all considered — and starts with the other trials at the site they just applied to.
One offer, once. A declined offer is never countered with a different study, and nobody is enrolled in a second trial without explicitly confirming it.
Public sources, cited and dated.
Nothing here is a proprietary database you have to take on faith. Every page cites its source and the date it was refreshed.
What we don’t do
See it on your own studies.
806 people applied through this pipeline in the last 45 days.
Type your site, clinic or hospital name.